University of Regensburg, Department of Psychology, Clinical Psychology and Psychotherapy, Germany.
Brigham Young University, Department of Psychology, United States.
J Psychosom Res. 2014 Jun;76(6):477-84. doi: 10.1016/j.jpsychores.2014.03.010. Epub 2014 Mar 29.
In previous studies of patients on-track to recovery (OT) involving therapists receiving only patient progress feedback without clinical support tools (CST) inconsistent results were found. Possible effects of combining patient progress feedback with CST on OT patients remain unclear.
At intake (t1), 252 patients of two in-patient psychosomatic clinics were randomized either into the experimental group (EG) or the treatment-as-usual control group (CG). Both groups were monitored weekly using the self-report instruments "Outcome Questionnaire" (OQ-45) and "Assessment of Signal Cases" (ASC). Therapists received weekly patient progress feedback (OQ-45) and CST feedback (ASC) only for EG patients starting at the week following intake (t2). Patients who did not deviate negatively from expected recovery curves by at least one standard deviation were considered OT patients (N=209; NEG=111; NCG=98). Since therapists received feedback at t2 for the first time, different patterns of change (OQ-45 scales) between the groups from t1 to t2, t2 to t3 (intake+two weeks), t2 to t4 (intake+three weeks), and t2 to t5 (last available OQ-45 score) were evaluated by multilevel models.
Merely from t2 to t3, the EG improved significantly more on the OQ-45 symptom distress scale than the CG (p<0.05; g=0.12).
Providing patient progress feedback and CST to therapists did not substantially surpass treatment-as-usual for OT patients in this explorative study except for a very small time-limited enhancement of symptom change.
在先前的研究中,对于即将康复的患者(OT),如果治疗师仅收到患者进展反馈,而没有临床支持工具(CST),则结果不一致。目前尚不清楚将患者进展反馈与 CST 相结合对 OT 患者的影响。
在入组时(t1),将 252 名来自两家身心诊所的住院患者随机分配到实验组(EG)或常规治疗对照组(CG)。两组患者每周使用自我报告工具“Outcome Questionnaire”(OQ-45)和“Assessment of Signal Cases”(ASC)进行监测。从入组后一周(t2)开始,治疗师每周仅为 EG 患者提供患者进展反馈(OQ-45)和 CST 反馈(ASC)。如果患者的恢复曲线没有偏离预期至少一个标准差,则认为患者 OT(N=209;NEG=111;NCG=98)。由于治疗师在 t2 时首次收到反馈,因此通过多层次模型评估了从 t1 到 t2、t2 到 t3(入组+两周)、t2 到 t4(入组+三周)以及 t2 到 t5(最后一次可获得的 OQ-45 评分)期间组间变化模式(OQ-45 量表)的差异。
仅仅从 t2 到 t3,EG 在 OQ-45 症状困扰量表上的改善明显大于 CG(p<0.05;g=0.12)。
在这项探索性研究中,除了在非常有限的时间内对症状变化的微小增强外,为治疗师提供患者进展反馈和 CST 并没有实质性地超越常规治疗。